文献速递艾滋病与性传播感染病毒性肝炎

直接抗病毒药物可快速从HIV合并HCV感染者肝脏清除丙型肝炎病毒但未完全逆转免疫激活

Direct-Acting Antivirals Quickly Eradicate Hepatitis C Virus From the Liver in People With Human Immunodeficiency Virus but Do Not Fully Reverse Immune Activation.
PubMed 文献 · J Infect Dis · 2025-01-01

研究纳入10例慢性基因1a型HCV感染者(其中5例为HIV/HCV共感染且ART抑制、CD4>200 cells/µL),接受索磷布韦-维帕他韦治疗,比较血浆HCV RNA、CXCL10及肝活检单细胞激光捕获显微切割的ISG变化。两组的血浆HCV RNA动力学无差异,DAAs在两组均快速清除肝内HCV,但共感染组的免疫激活下降更慢,ISG表达在单感染组降低而在共感染组升高。

要点

  • DAAs在HCV单感染与HIV/HCV共感染中均快速清除肝内HCV。
  • 共感染组CXCL10下降但至治疗结束仍高于单感染组。
  • ISG表达在单感染组降低而在共感染组升高,免疫激活消退更慢。

核心结论

  • DAAs在两组均快速清除肝内HCV,但HIV感染者的免疫激活消退较慢,残留免疫激活需进一步探索。

研究设计与样本

  • 研究纳入10例慢性基因1a型HCV感染者,其中5例为HIV/HCV共感染且ART抑制病毒血症、CD4+ T细胞计数>200 cells/µL,接受索磷布韦-维帕他韦治疗。
  • 采用单细胞激光捕获显微切割对DAA起始前及起始后4-7天内的肝活检组织进行检测,以评估HCV清除和干扰素刺激基因(ISG)变化。

主要发现

  • 两组间血浆HCV RNA第一相和第二相动力学无差异。
  • 活检1时感染肝细胞比例中位数(最小值-最大值)在HCV单感染为0.06(0.01-0.59),在HIV/HCV共感染为0.21(0.04-0.87),两者无差异。
  • 活检2时参与者细胞内HCV RNA水平降低。
  • CXCL10水平在两组均下降,但共感染组即使治疗结束时仍高于单感染组。
  • 表达ISG的细胞比例在单感染组降低,在共感染组升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis C virus (HCV) infects nearly one-fourth of people with human immunodeficiency virus (HIV). The role of direct-acting antivirals (DAAs) on immune activation in people with HIV (PWH) and HCV is poorly understood. METHODS: We quantified plasma HCV RNA and CXCL10 in persons with HCV monoinfection versus HIV/HCV coinfection receiving sofosbuvir-velpatasvir. Single-cell laser capture microdissection was applied to liver biopsies obtained before and within 4-7 days of DAA initiation to estimate HCV clearance and changes in interferon-stimulated genes (ISGs). RESULTS: We enrolled 10 people with chronic genotype 1a HCV: 5 were PWH with ART-suppressed viremia and CD4+ T cell counts >200 cells/µL. First- and second-phase plasma HCV RNA kinetics were not different between groups. Median (min-max) proportions of infected hepatocytes at biopsy 1 were 0.06 (0.01-0.59) in HCV monoinfection and 0.21 (0.04-0.87) in HIV/HCV coinfection and did not differ. Participants had lower intracellular HCV RNA levels at biopsy 2. CXCL10 levels declined in both groups but were higher in coinfection than in monoinfection even at the end of treatment. The proportion of cells expressing ISGs diminished in monoinfection but increased in coinfection. CONCLUSIONS: Whereas DAAs rapidly cleared intrahepatic HCV in both groups, immune activation was slower to diminish in PWH. Residual immune activation in PWH warrants further exploration. Clinical Trials Registration. NCT02938013.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Sachithanandham J, Leep-Lazar J, Quinn J, et al. Direct-Acting Antivirals Quickly Eradicate Hepatitis C Virus From the Liver in People With Human Immunodeficiency Virus but Do Not Fully Reverse Immune Activation. J Infect Dis. 2025. PMID: 39656808. doi:10.1093/infdis/jiae598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。